Drug Database · Clinicians

Clopidogrel

Brands (144) Anticlop, Ategra, Clopinova…Show all
Anticlop · Ategra · Clopinova · Clopisure · Clopivate · Clopixel · Cloverta · Colife · Copide · Gropid · Hemoflow · Noklot · Platexan · Plavix · Akrogrel · Angiogrel · Angiostar 75 · Anplat · Arnoplet · Cardigrel · Cardiplat · Cardogrel · Cassagrel · Castegrel · Cigrel-75 · Clapidz · Class · Clodi · Cloduz · Cloed · Clogeovix · Clogrel · Clogretab · Clogrix · Cloheal · Clomep · Clopate · Clopegen · Clopend-75 · Clophil · Clopi-Health · Clopicard · Clopiclot · Clopida · Clopidamond · Clopidcura · Clopido-M · Clopidogen · ClopidoMed · Clopidowel-75 · Clopidra · Clopidrel · Clopierra · Clopifar · Clopifirst · Clopilar · Clopimed · Clopinav · Clopisky · CLOPISTAN · Clopivaz · Clopiwin-75 · Clopix · Cloplat · Clopsil · Clored · Clorel · Clotfixmed · Clotfre · Clotimax · CLOTIN · Clotiz · Clotstop · Clovas · Clovel · Clovixa · Combiplate · CONTRACLOT · Corplet · Deplatt · Diapid · Domidon · Dopirel · Dorell · Drhel · Fedgrel · Flamdovix · Flavix · Gopid · Grelpill · Hemaclid · Hemaflow · Khrizvix · Klopi · Klopide · Klopido · Lifegrel · Lopimax · Loprel · Medogrel · Milopid 75 · MUGREL · Navorel · Neoclopid · NOCLOT · Norplat · Nuclot · OP-Reduclot · Oragrel · Pharmagrel · Pidogrel · Pigrel · Plagerine · Plasmabloc · Plat-Low · Platclo · Platikon · Platz · Plavicar · Plavido · Plavihex · Plogrel · Plogril · Primevix · Puril · Retaplav · Saphlopid · SAPHLOPID-GE75 · Shegrel · Skygrel · Syclopid · Sydogrel · T-Clot · Thrombicare · Timibest · Tridogrel · Trombix · Valdon · Vasclorix · Vexagril 75 · Vivelon · Xerevo · Zandropil · Zeroclot

Antithrombotic agent (platelet aggregation inhibitor); Antithrombotic (platelet aggregation inhibitor excel. heparin); and others PH FDA category

Rx · Prescription drug196 PH productsPNF-listedPhilHealth GAMOT
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID de8b0b67-eb25-4684-83b5-7ad785314227, version date May 30, 2025 (Plavix · Sanofi-Aventis U.S. LLC). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • Acute coronary syndrome – For patients with non–ST-segment elevation ACS (unstable angina [UA]/non–ST-elevation myocardial infarction [NSTEMI]), Plavix has been shown to reduce the rate of myocardial infarction (MI) and…
  • – For patients with ST-elevation myocardial infarction (STEMI), Plavix has been shown to reduce the rate of MI and stroke.
  • Recent MI, recent stroke, or established peripheral arterial disease.
US FDA label
Full indications and usage US FDA label

1 INDICATIONS AND USAGE Plavix is a P2Y 12 platelet inhibitor indicated for: Acute coronary syndrome – For patients with non–ST-segment elevation ACS (unstable angina [UA]/non–ST-elevation myocardial infarction [NSTEMI]), Plavix has been shown to reduce the rate of myocardial infarction (MI) and stroke. (1.1) – For patients with ST-elevation myocardial infarction (STEMI), Plavix has been shown to reduce the rate of MI and stroke.

(1.1) Recent MI, recent stroke, or established peripheral arterial disease. Plavix has been shown to reduce the rate of MI and stroke. (1.2) 1.1 Acute Coronary Syndrome (ACS) Plavix is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non–ST-segment elevation ACS (unstable angina [UA]/non–ST-elevation myocardial infarction [NSTEMI]), including patients who are to be managed medically and those who are to be managed with coronary revascularization.

Plavix should be administered in conjunction with aspirin. Plavix is indicated to reduce the rate of myocardial infarction and stroke in patients with acute ST-elevation myocardial infarction (STEMI) who are to be managed medically. Plavix should be administered in conjunction with aspirin. 1.2 Recent MI, Recent Stroke, or Established Peripheral Arterial Disease In patients with established peripheral arterial disease or with a history of recent myocardial infarction (MI) or recent stroke Plavix is indicated to reduce the rate of MI and stroke.

Contraindications

4 CONTRAINDICATIONS Active pathological bleeding, such as peptic ulcer or intracranial hemorrhage (4.1) Hypersensitivity to clopidogrel or any component of the product (4.2) 4.1 Active Bleeding Plavix is contraindicated in patients with active pathological bleeding such as peptic ulcer or intracranial hemorrhage. 4.2 Hypersensitivity Plavix is contraindicated in patients with hypersensitivity (e.g., anaphylaxis) to clopidogrel or any component of the product [see Adverse Reactions (6.2)].

US FDA label

Dosing: Adult

Dosage and administration (US label) US FDA label
  • Acute coronary syndrome (2.1)
  • – Initiate Plavix with a single 300 mg oral loading dose and then continue at 75 mg once daily. – Initiating Plavix without a loading dose will delay establishment of an antiplatelet effect by several days. Recent MI, recent stroke, or established peripheral arterial disease: 75 mg once daily orally without a loading dose. (2.2)
2.1 Acute Coronary Syndrome

2.1 Acute Coronary Syndrome In patients who need an antiplatelet effect within hours, initiate Plavix with a single 300 mg oral loading dose and then continue at 75 mg once daily. Initiating Plavix without a loading dose will delay establishment of an antiplatelet effect by several days [see Clinical Pharmacology (12.3) and Clinical Studies (14.1)].

2.2 Recent MI

2.2 Recent MI, Recent Stroke, or Established Peripheral Arterial Disease 75 mg once daily orally without a loading dose [see Clinical Pharmacology (12.3) and Clinical Studies (14.2)].

Dosing: Altered kidney function

From the US FDA label · Renal impairment (use in specific populations)

8.6 Renal Impairment Experience is limited in patients with severe and moderate renal impairment [see Clinical Pharmacology (12.2)].

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosing: Hepatic impairment

8.7 Hepatic Impairment No dosage adjustment is necessary in patients with hepatic impairment [see Clinical Pharmacology (12.2)].

US FDA label

Dosing: Pediatric

Pediatric use (US label) US FDA label

8.4 Pediatric Use Safety and effectiveness in pediatric populations have not been established. A randomized, placebo-controlled trial (CLARINET) did not demonstrate a clinical benefit of clopidogrel in neonates and infants with cyanotic congenital heart disease palliated with a systemic-to-pulmonary arterial shunt. Possible factors contributing to this outcome were the dose of clopidogrel, the concomitant administration of aspirin, and the late initiation of therapy following shunt palliation.

It cannot be ruled out that a trial with a different design would demonstrate a clinical benefit in this patient population.

Dosing: Older adult

Geriatric use (US label) US FDA label

8.5 Geriatric Use Of the total number of subjects in the CAPRIE and CURE controlled clinical studies, approximately 50% of patients treated with Plavix were 65 years of age and older, and 15% were 75 years and older. In COMMIT, approximately 58% of the patients treated with Plavix were 60 years and older, 26% of whom were 70 years and older.

The observed risk of bleeding events with Plavix plus aspirin versus placebo plus aspirin by age category is provided in Table 1 and Table 2 for the CURE and COMMIT trials, respectively [see Adverse Reactions (6.1)]. No dosage adjustment is necessary in elderly patients.

Dosage forms

Philippines

  • Film-coated tablet: 75 mg, 300 mg
  • Tablet: 75 mg
  • Film – coated tablet: 75 mg
  • Film–coated tablet: 75 mg
  • Syrup: 6 mg/mL

Registered products in the Philippines

196 products registered with the Food and Drug Administration (FDA) Philippines list Clopidogrel as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Also registered under: Clopidgrel (as bisulfate) (1 product) · Clopidrogel (as bisulfate) (1 product). Products registered under these spellings are included in the table and marked.

Verify on PH FDA portal

All registered products196
Philippine FDA-registered products for Clopidogrel
Package insert
AkrogrelClopidgrel (as bisulfate)Variant spelling
75 mg Film-Coated TabletAlu/PVC blister pack x 15's (Box of 30's)
Rx
Akriti Pharmaceuticals Pvt. Ltd.India
Aglobal Care, Inc.Trader: N/A
DRP-16737
Jul 1, 2030
AngiogrelClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14’s)
Rx
Sandoz Private LimitedIndia
TGP Pharma Inc.Importer: Sandoz Philippines Corporation
DRP-2123-01
Oct 14, 2029
Angiostar 75Clopidogrel
75mg Film-Coated TabletALU/ALU Blister pack 3 X 10's in a box
Rx
Celogen Generics Private Ltd.India
Pharmastar International Trading Corporation
DRP-11769
Apr 27, 2027
AnplatClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's and 100's)
Rx
Zim Laboratories LimitedIndia
Better Option Pharmaceuticals, Inc.Importer: Orange Biotec Inc.Trader: Amegh Pharma Pvt. Ltd.
DRP-3250
Sep 20, 2031
AnticlopClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Zim Laboratories LimitedIndia
Teramedix Pharma Trading Inc.
DRP-16500
Mar 14, 2027
AnticlopClopidogrel (as bisulfate)
75mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Zim Laboratories LimitedIndia
Teramedix Pharma Trading Inc.
DR-XY47816
Mar 14, 2027
ArnopletClopidogrel (as Bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Saga LaboratoriesIndia
Hexagon Pharmaceuticals
DR-XY40696
Mar 30, 2027
AtegraClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Bafna Pharmaceuticals LimitedIndia
Novocore Pharma Inc.Importer: Medethix, Inc.
DRP-16366-01
Feb 20, 2030
AtegraClopidogrel (as Bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Mepro Pharmaceuticals Private LimitedIndia
Oxpharma Inc.Importer: Medethix Inc.
DRP-8514-06
Nov 22, 2027
CardigrelClopidogrel (as Bisulfate)
75 mg Film-Coated TabletAlu-Alu Blister Pack Of 10'S (Box Of 30'S. Box Of 100'S)
Rx
Windlas Biotech Limited (Plant 2)India
Synergia Health Care & Life Sciences, Inc.
DRP-19056
Oct 21, 2031
CardiplatClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s; Box of 100’s)
Rx
Zim Laboratories LimitedIndia
GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc.
DRP-9166-08
Oct 30, 2031
CardogrelClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 7's Box of 14's
Rx
Sandoz Private LimitedIndia
Sandoz Philippines Corporation
DRP-2123
Oct 14, 2029
CassagrelClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister pack x 10's (Box of 100's)
Rx
Zim Laboratories LimitedIndia
Cassandras Care Pharmaceutical DistributorImporter: Medinova Pharmaceutical Inc.
DRP-9166-02
Oct 30, 2031
CastegrelClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Stallion Laboratories Pvt. Ltd.India
Castellano DrugImporter: Ambica International Corporation
DRP-2672-11
Jan 4, 2029
Cigrel-75Clopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack 5 x 10's (Box of 50's); Alu/Alu Blister Pack 10 x 10's (Box of 100's)
Rx
Stallion Laboratories Pvt. Ltd.India
Medcare PharmaceuticalsImporter: Ambica International Corporation
DRP-5426
Aug 8, 2029
ClapidzClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Stallion Laboratories Pvt. Ltd.India
D&G PharmaImporter: Ambica International Corporation
DRP-2672-09
Jan 4, 2029
ClassClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Stallion Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-2672
Jan 4, 2029
ClodiClopidogrel (as Bisulfate)
75mg Film-Coated TabletAlu/Alu Blister pack x 10's Box of 30's and 100's
Rx
MEPRO PHARMACEUTICALS Private LimitedIndia
AFFOMEDZ INC.Importer: MEDETHIX INC.
DRP-8514-02
Nov 22, 2027
CloduzClopidogrel (As bisuIfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's, & 100's)
Rx
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-10878-04
Dec 10, 2026
CloedClopidogrel
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Centurion Laboratories Pvt. Ltd.India
Harlem SalesImporter: Philgen Pharmaceuticals Inc.
DRP-11057-08
Jan 20, 2027
ClogeovixClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's, 30's and 100's)
Rx
Medico Remedies LimitedIndia
MedEthix, Inc.Importer: I.E. Medica, Inc.
DRP-4539
Jul 23, 2028
ClogrelClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Surien Pharmaceuticals (P) Ltd.India
Brel Pharmaceutical Inc.
DR-XY41804
Mar 14, 2028
ClogretabClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Stallion Laboratories Pvt. Ltd.India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation
DRP-2672-13
Jan 4, 2029
ClogrixClopidogrel (as bisuIfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's & 100's)
Rx
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-10878-07
Dec 10, 2026
ClohealClopidogrel
75 mg Film–Coated TabletAlu/Alu Blister Pack x 10’s (Box of 50’s and 100’s)
Rx
Stallion Laboratories Pvt. Ltd.India
Suhitas Pharmaceuticals Inc.Trader: Mac Heal Laboratories Ltd.
DRP-1791
Aug 17, 2029
ClomepClopidogrel (as bisulfate)
75 mg Film - Coated TabletAlu/Alu Blister pack x 10's Box of 30's and 100's
Rx
MEPRO Pharmaceutical Private LimitedIndia
MEEDPHARMA MEDICAL SUPPLIES & EQUIPMENT DISTRIBUTORImporter: MEDETHIX INC.
DRP-8514-04
Nov 22, 2027
ClopateClopidogrel
75 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 10's & Box of 30's)
Rx
Unicure Remedies Pvt. LtdIndia
ECE Pharmaceuticals, Inc.Importer: AAA Pharma, Inc.
DR-XY41747
Feb 25, 2028
ClopegenClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Zim Laboratories LimitedIndia
Reta DrugImporter: Medinova Pharmaceutical Inc.
DRP-9166-01
Oct 30, 2031
Clopend-75Clopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Stallion Laboratories Pvt. Ltd.India
Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd.
DRP-4698
Sep 13, 2028
ClophilClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
Rx
Stallion Laboratories Pvt. Ltd.India
Phil Asia Pharma IncImporter: Ambica International Corporation
DRP-2672-05
Jan 4, 2029
Clopi-HealthClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
Rx
Sapphire Lifesciences Pvt. Ltd.India
HEALTHWINDS MEDICAL TRADING CORPImporter: Nelpa Lifesciences, Inc.
DRP-7384-
Oct 4, 2027
ClopicardClopidogrel (as bisulfate)
75mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Zim Laboratories LimitedIndia
Life And Health Source Pharmaceutical Distribution Co.Importer: Medinova Pharmaceutical Inc.
DRP-9166-06
Feb 7, 2032
ClopiclotClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/PVC Blister Pack of 10's (Box of 100's)
Rx
J. Duncan Healthcare Pvt. LtdIndia
Neos-King Pharma Inc.Importer: Grovic Pharma Inc.
DRP-12391-03
Jul 13, 2027
ClopidaClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
Rx
XL Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-1885
Sep 8, 2029
ClopidamondClopidogrel (as Bisulfate)
75 mg TabletAluminum Foil Strip x 4's (Box of 100's)
Rx
Diamond Laboratories Inc.Philippines
Tobie Pharma, Inc.
DRP-7604-01
Apr 11, 2029
ClopidcuraClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 10's, 30's, 50's and 100's)
Rx
BDA Healthcare Pvt. Ltd.India
RVM Pharma & Medical Supplies DistributionImporter: Orange Biotec, Inc.
DRP-15765-02
Sep 12, 2029
Clopido-MClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
Rx
Zim Laboratories LimitedIndia
Rilem Pharma Corp.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-4528
Nov 6, 2031
ClopidogenClopidogrel
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Zim Laboratories, LimitedIndia
Quad-Gen PharmaceuticalsImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-4528-03
Dec 6, 2026
ClopidoMedClopidogrel (as bisulfate)
75mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Rhydburg Pharmaceuticals Limited.India
Dreamax IncorporatedTrader: Oak and Zen
DRP-14839
Jan 22, 2029
Clopidowel-75Clopidogrel (as bisulfate)
75 mg Film-Coated TabletClear PVC/Alu Blister Pack x 10’s (Box of 100’s)
Rx
Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)India
Guimhealth Pharmaceutical Distributor & DrugstoreImporter: Ambica International CorporationTrader: Unosource Pharma Ltd.
DRP-3126
Jul 14, 2029
ClopidraClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Strip Foil x 4's (Box of 12's and 100's); Alu/Alu Strip Foil x 4's (Box of 8's as Physician's Sample); Alu/Alu Strip Foil x 2's (Box of 2's as Physician's Sample)
Rx
Interphil Laboratories, Inc.Philippines
—
DRP-3793
Jun 13, 2028
ClopidrelClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/White PVC Blister Pack x 10's (Box of 50's and 100's)
Rx
Medisure Laboratories Pakistan (Pvt.) LimitedPakistan
Accesspoint International Trading Inc.
DRP-6042
Mar 13, 2030
ClopierraClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Magbro Healthcare Pvt. Ltd.India
Sierra Pharmaceutical CorporationImporter: Pharmakon Biotec Inc.
DRP-10878-10
Dec 10, 2026
ClopifarClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's); Alu/Clear PVC Blister Pack x 10's (Box of 30's)
Rx
Bal Pharma LimitedIndia
Conjug8 Corp.Importer: Pharmakon Biotec Inc.
DRP-4875
Oct 29, 2028
ClopifirstClopidogrel
75 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
Rx
J.M. Tolmann Laboratories Inc.Philippines
Firstmed Theraconcept Inc.
DRP-2470-10
Feb 2, 2030
ClopilarClopidogrel
75 mg Film – Coated TabletAlu/Alu Blister Pack x 10’s (Box of 50’s and 100’s)
Rx
Stallion Laboratories Pvt. Ltd.India
Better Option Pharmaceuticals, Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: Mac Heal Laboratories Ltd.
DRP-1791-03
Aug 17, 2029
ClopimedClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Medchem International LimitedIndia
Pharma-Surrey International, Inc.
DR-XY39280
Apr 7, 2031
ClopinavClopidogrel (as bisulfite)
75 mg Film-Coated TabletAlu/White PVC Blister Pack x 10's (Box of 100's)
Rx
Medisure Laboratories Pakistan (Pvt.) LimitedPakistan
Rexmed Pharmaceutical SalesImporter: Accesspoint International Trading Inc.
DRP-6042-02
Mar 13, 2030
ClopinovaClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
Rx
Zim Laboratories LimitedIndia
Medinova Pharmaceutical Inc.
DRP-9166
Sep 21, 2030
ClopinovaClopidogrel (as bisulfate)
75mg Film Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's and Box of 100's)
Rx
S Kant Healthcare Ltd.India
Medinova Pharmaceutical Inc.
DRP-18339
Jun 16, 2031
ClopiskyClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s; Box of 100’s)
Rx
Zim Laboratories LimitedIndia
Skymed Pharma DistributorImporter: Medinova Pharmaceutical Inc.
DRP-9166-09
Oct 14, 2031
CLOPISTANCLOPIDOGREL
75 MG FILM-COATED TABLETALU / ALU BLISTER PACK X 10'S (Box of 30's)
Rx
J.M. TOLMANN LABORATORIES INC.Philippines
GOLD LIFE DISTRIBUTION PHILS. INC.
DRP-2470-13
Feb 2, 2030
ClopisureClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack of x 10's (Box of 100's)
Rx
Magbro Healthcare Pvt. Ltd.India
Rule Med Pharma Corp.Importer: Pharmakon Biotec Inc.
DRP-10878-11
Dec 10, 2026
ClopisureClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu / Alu Blister Pack x 10's (Box of 100's)
Rx
Zim Laboratories LimitedIndia
Rule Med Pharma Corp.Importer: Teramedix Pharma Trading Inc.
DRP-16500-01
Mar 14, 2027
ClopivateClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's and Box of 100's)
Rx
S Kant Healthcare Ltd.India
K Pharma Medical Corp.Importer: Medinova Pharmaceutical Inc.
DRP-18339-01
Jun 16, 2031
ClopivateClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
Rx
Zim Laboratories LimitedIndia
K Pharma Medical Corp.Importer: Medinova Pharmaceutical Inc.
DRP-9166-12
Sep 21, 2030
ClopivazClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Lloyd Laboratories, Inc.Philippines
Trader: Innogen Pharmaceuticals, Inc.
DRP-15262
Jul 26, 2031
Clopiwin-75Clopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
Rx
Mediwin PharmaceuticalsIndia
Ambica International Corporation
DRP-6560
Oct 10, 2030
ClopixClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Lloyd Laboratories, Inc.Philippines
Trader: Medhaus Pharma, Incorporated
DR-XY37363
Jan 19, 2030
ClopixelClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's and Box of 100's)
Rx
S Kant Healthcare Ltd.India
Medcare PharmaceuticalsImporter: Medinova Pharmaceutical Inc.
DRP-18339-02
Jun 16, 2031
ClopixelClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
Rx
Zim Laboratories LimitedIndia
Medcare PharmaceuticalsImporter: Medinova Pharmaceutical Inc.
DRP-9166-13
Sep 21, 2030
CloplatClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/ Alu Blister Pack x 10's (Box of 30's)
Rx
Stallion Laboratories Pvt. Ltd.India
OEP Philippines, Inc.Importer: Ambica International Corporation
DRP-2672-17
Jan 4, 2029
ClopsilClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
Rx
XL Laboratories Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-1885-01
Sep 8, 2029
CloredClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
Rx
Sapphire Lifesciences Pvt. Ltd.India
777 Red Pharma Inc.Importer: Nelpa Lifesciences, Inc.
DRP-7384-02
Oct 4, 2027
ClorelClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu / Alu Blister Pack x 10’s (Box of 100’s)
Rx
Hizon Laboratories, Inc.Philippines
Crisdy-Na Drug Corporation
DRP-6838-03
Nov 17, 2029
ClotfixmedClopidogrel
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Zim Laboratories, LimitedIndia
TGP Pharma Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-4528-02
Dec 3, 2026
ClotfreClopidogrel
75 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 30's and 100's)
Rx
Raptakos, Brett & Co., LtdIndia
Raptakos, Brett & Co., Ltd
DRP-10037
Aug 6, 2030
ClotimaxClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Magbro Healthcare Pvt. Ltd.India
Sigma Medical Solution Trading Co. Inc.Importer: Pharmakon Biotec Inc.
DRP-10878-06
Dec 10, 2026
CLOTINCLOPIDOGREL
75 MG FILM-COATED TABLETALU - ALU BLISTER PACK X 10'S BOX OF 30'S
Rx
J.M. TOLMANN LABORATORIES INC.Philippines
CHMI PHARMA, INC.
DRP-2470-14
Feb 2, 2030
ClotizClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu-Alu Blister pack x 10's (Box of 30's and 100's)
Rx
Hizon Laboratories, Inc.Philippines
Chira Pharmaceuticals, Inc.
DRP-6838-01
Nov 17, 2029
ClotstopClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Magbro Healthcare Pvt. Ltd.India
One Technodrug Life Sciences Inc.Importer: Pharmakon Biotec Inc.
DRP-10878-08
Dec 10, 2026
ClovasClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
Rx
Lloyd Laboratories, Inc.Philippines
Trader: Solvang Pharmaceuticals, Inc.
DRP-4028
Oct 22, 2031
ClovelClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/PVC Blister Pack of 10's (Box of 100's)
Rx
J. Duncan Healthcare Pvt. Ltd.India
SEA-King Pharma Inc.Importer: Grovic Pharma Inc.
DRP-12391-2
Jul 13, 2027
ClovertaClopidogrel
75 mg Film – Coated TabletAlu/Alu Blister Pack x 10’s Box of 50’s and 100’s
Rx
Stallion Laboratories Pvt. Ltd.India
HLM Pharmaceutical Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: Mac Heal Laboratories Ltd.
DRP-1791-05
Aug 17, 2029
ClovertaClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
Rx
Zim Laboratories LimitedIndia
HLM Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc.
DRP-9166-11
Sep 22, 2031
ClovixaClopidogrel (As Bisulfate)
75mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
The ACME Laboratories LimitedBangladesh
Bell-Kenz Pharma Inc.Importer: Euro Generics International Phils., Inc.
DRP-2213
Aug 12, 2027
ColifeClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s and 100’s)
Rx
Fredun Pharmaceuticals LimitedIndia
Life And Health Source Pharmaceutical Distribution Co.Importer: AMB HK Enterprises Inc.
DRP-12515-01
Aug 25, 2027
ColifeClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Globela Pharma Private LimitedIndia
Life and Health Source Pharmaceutical Distribution Co.Importer: AMB HK Enterprises Inc.
DRP-13933-02
May 18, 2028
CombiplateClopidogrel (as bisulfate)
75 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
Rx
Hebei Tiancheng Pharmaceutical Co., Ltd.China
AMB HK Enterprises Inc.
DRP-16511
Apr 7, 2030
CONTRACLOTCLOPIDOGREL
75 MG FILM-COATED TABLETALU / ALU BLISTER PACK X 10'S (BOX OF 30'S)
Rx
J.M. Tolmann Laboratories Inc.Philippines
Medirich Pharma Distribution Corp
DRP-2470-11
Feb 2, 2030
CopideClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 30's and 100's)
Rx
Globela Pharma Private LimitedIndia
PhilRx Pharma Inc.
DRP-11594
Mar 31, 2032
CopideClopidogrel (as bisulfate)
75mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Globela Pharma Private LimitedIndia
AMB HK Enterprises, Inc.Importer: AMB HK Enterprises Inc.
DRP-13489
Feb 27, 2028
CorpletClopidogrel (as Bisulfate)
75mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
Rx
MEPRO PHARMACEUTICALS PRIVATE LIMITEDIndia
MC GRAW PHARMA INC.Importer: MEDETHIX INC.
DRP-8514
Nov 22, 2027
DeplattClopidogrel (as Bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Torrent Pharmaceuticals LimitedIndia
Torrent Pharma Philippines, Inc.
DRP-2681
Dec 21, 2029
DiapidClopidogrel (as Bisulfate)
75 mg TabletAluminum Strip Foil of 4's Box of 100's
Rx
Diamond Laboratories Inc.Philippines
Full Health International Pharma
DRP-7604
Apr 11, 2029
DomidonClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/PVC Blister pack x 10's (Box of 10's)
Rx
BDA Healthcare Pvt. Ltd.India
Orange Biotec Inc.
DRP-15765
Sep 12, 2029
DopirelClopidogrel
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30's)
Rx
Zim Laboratories LimitedIndia
Suhitas Pharmaceuticals Inc.Trader: PSA International (Export Division of PSA chemicals & Pharmaceuticals Pvt. Ltd.
DRP-1674
Oct 28, 2029
DorellClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
Rx
Stallion Laboratories Pvt. Ltd.India
Starpharm, Inc.Importer: Ambica International Corporation
DRP-2672-03
Jan 4, 2029
DrhelClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Stallion Laboratories Pvt. Ltd.India
Diafarm Inc.Importer: Ambica International Corporation
DRP-2672-18
Jan 4, 2029
FedgrelClopidogrel (as bisulfate)
75mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Globela Pharma Private LimitedIndia
AMB HK Enterprises, Inc.Importer: AMB HK Enterprises Inc.
DRP-13933
May 18, 2028
FlamdovixClopidogrel
75 mg TabletAlu/Alu Blister Pack x 10’s (Box of 100's)
Rx
Flamingo Pharmaceuticals Ltd.India
Hexagon Pharmaceuticals
DRP-2140
Oct 26, 2029
FlavixClopidogrel
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Centurion Laboratories Pvt. Ltd.India
Steinbach Products Inc.Importer: Philgen Pharmaceuticals Inc.
DRP-11057-01
Jan 20, 2027
GopidClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
Rx
Stallion Laboratories Pvt. Ltd.India
Applied Pharmaceutical Distribution IncImporter: Ambica International Corporation
DRP-2672-02
Jan 4, 2029
GrelpillClopidogrel (As Bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10 Blister packs x 10 Tablets)
Rx
Stallion Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-13205
Dec 28, 2027
GropidClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/PVC Blister Pack of 10's (Box of 100's)
Rx
J. Duncan Healthcare Pvt. Ltd.India
GROVIC PHARMA INC.
DR-XY45960
Jul 13, 2027
GropidClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/PVC Blister Pack of 10's (Box of 100's)
Rx
J. Duncan Healthcare Pvt. Ltd.India
Grovic Pharma Inc.
DRP-12391
Jul 13, 2027
HemaclidClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's ); Alu/Alu Blister Pack x 10's (Box of 50's & 100's)
Rx
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-10878-3
Dec 10, 2026
HemaflowClopidogrel
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10 's Box of 30's
Rx
Hovid BerhadMalaysia
Hovid Inc.
DR-XY36848
Oct 21, 2029
HemoflowClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's and Box of 100's)
Rx
S Kant Healthcare Ltd.India
New Seammed IncImporter: Medinova Pharmaceutical Inc.
DRP-18339-03
Jun 16, 2031
HemoflowClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s and 100’s)
Rx
Zim Laboratories LimitedIndia
New Seammed Inc.Importer: Medinova Pharmaceutical Inc.
DRP-9166-10
Oct 30, 2031
KhrizvixClopidogrel (as bisulfate)
75mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 30's)
Rx
Fredun Pharmaceuticals Ltd.India
Khriz Pharma Trading Inc.
DRP-11514
Mar 30, 2027
KlopiClopidogrel (as Bisulfate)
75 mg Film-Coated TabletAlu/Clear PVC/PVDC Blister Pack x 10’s (Box of 30's and 50's)
Rx
Kusum Healthcare Private LimitedIndia
Kusum Healthcare Private Limited Branch Office
DRP-11521
Mar 12, 2031
KlopideClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
Rx
Lloyd Laboratories, Inc.Philippines
Ultramed Pharma, Inc.Trader: Solvang Pharmaceuticals, Inc.
DRP-4028-04
Aug 19, 2031
KlopidoClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
Rx
Lloyd Laboratories, Inc.Philippines
Totalcare Pharma Inc.Trader: Solvang Pharmaceuticals, Inc.
DRP-4028-01
Jul 20, 2031
LifegrelClopidogrel (as bisulfate)
75 mg Film-Coated TabletClear PVC/Alu Blister x 10’s Box of 100’s
Rx
Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)India
Radbuster Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd.
DRP-3126-03
Jul 14, 2029
LopimaxClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Kyung Dong Pharm Co., Ltd.Republic of Korea
Bliss Pharma Distribution and Consultancy Corp.
DRP-3837
Dec 22, 2026
LoprelClopidogrel
75 mg Film-Coated TabletAlu-Alu Blister Pack X 10's Box of 30's
Rx
J.M. Tolmann Laboratories Inc.Philippines
Medirich Pharma Distribution Corp.
DRP-2470-08
Feb 2, 2030
MedogrelClopidogrel (as Bisulfate)
75 mg Film coated tabletAlu/Alu Blister Pack x 10's (Box of 10's, 30's and 100's)
Rx
Medico Remedies LimitedIndia
Medethix, Inc.
DRP-4538
Jul 23, 2028
Milopid 75Clopidogrel
75 mg Film – Coated TabletAlu/Alu Blister Pack x 10’s (Box of 50’s and 100’s)
Rx
Stallion Laboratories Pvt. Ltd.India
Jjysrinn Trading Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: Mac Heal Laboratories Ltd.
DRP-1791-06
Aug 17, 2029
MUGRELClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/PVC Blister Pack of 10's (Box of 100's)
Rx
J. Duncan Healthcare Pvt. Ltd.India
Multigro Healthcare Inc.Importer: Grovic Pharma Inc.
DRP-12391-01
Jul 13, 2027
NavorelClopidogrel (as bisulfate)
75 mg Film-Coated TabletClear PVC/Alu Blister x 10’s (Box of 100’s)
Rx
Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)India
Ambicare Pharmaceuticals, Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd.
DRP-3126-01
Jul 14, 2029
NeoclopidClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Stallion Laboratories Pvt. Ltd.India
GX International, Inc.Importer: Ambica International Corporation
DRP-2672-15
Jan 4, 2029
NOCLOTCLOPIDOGREL
75 MG FILM-COATED TABLETAlu-Alu Blister Pack x 10's (Box of 30's)
Rx
J.M. TOLMANN LABORATORIES INC.Philippines
WESTFIELD PHARMACEUTICALS, INC.
DRP-2470-12
Feb 5, 2030
NoklotClopidogrel (as bisulfate)
75 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's); Alu/Alu Blister Pack x 10's (Box of 10's) as Physician's Sample
Rx
Cadila Healthcare LimitedIndia
Zydus Healthcare Philippines, Inc.
DRP-11517
Apr 1, 2027
NoklotClopidogrel (as Bisulfate)
75 mg Film-Coated TabletAlu/Clear PVC Blister Pack by 10's (Box of 30's)
Rx
Cadila Healthcare LimitedIndia
Zydus Healthcare Philippines, Inc.
DRP-881
May 26, 2029
NoneClopidogrel
75 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
Rx
Centurion Laboratories Pvt. Ltd.India
TGP Pharma Inc.Importer: Philgen Pharmaceuticals, Inc
DRP 11057-02
Jan 20, 2027
NoneClopidogrel
75 mg Film Coated TabletAlu / Alu Blister Pack x 10's (Box of 100's)
Rx
Centurion Laboratories Pvt. Ltd.India
Better Option Pharmaceuticals, Inc.Importer: Philgen Pharmaceuticals, Inc.
DRP-11057-05
Jan 20, 2027
NoneClopidogrel (as bisulfate)
75 mg Film Coated TabletAlu/Alu Strip Foil x 4's (Box of 100's); Alu/Alu Strip Foil x 4's (Box of 8's) [Physician's Sample]
Rx
Interphil Laboratories, Inc.Philippines
St. Joseph Drugstore
DRP-3793-04
Jun 13, 2028
NoneClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
Rx
Lloyd Laboratories, Inc.Philippines
Trader: Dyna Drug Corporation
DR-XY38777
Nov 19, 2030
NoneClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
Rx
Hizon Laboratories, Inc.Philippines
—
DR-XY43711
Sep 17, 2029
NoneClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's and 100's)
Rx
Magbro Healthcare Pvt. Ltd.India
Alkem Laboratories CorporationImporter: Pharmakon Biotec Inc.
DRP-10878-02
Dec 10, 2026
NoneClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu-Alu Blister Pack x 7's (Box of 14's)
Rx
Sandoz Private LimitedIndia
Ritemed Phils., Inc.Importer: Sandoz Philippines Corporation
DRP-2123-04
Oct 14, 2029
NoneCLOPIDOGREL
75 MG FILM-COATED TABLETALU - ALU BLISTER PACK X 10'S (BOX OF 30'S)
Rx
J.M. TOLMANN LABORATORIES INC.Philippines
—
DRP-2470
Feb 2, 2030
NoneClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 100's)
Rx
Stallion Laboratories Pvt. Ltd.India
TGP Pharma Inc.Importer: Ambica International Corporation
DRP-2672-14
Jan 4, 2029
NoneClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Stallion Laboratories Pvt. Ltd.India
OEP Philippines, Inc.Importer: Ambica International Corporation
DRP-2672-16
Jan 4, 2029
NoneClopidogrel (as Bisulfate)
75 mg Film-Coated TabletClear PVC/Alu Blister Pack x 10’s (Box of 100's)
Rx
Akums Drugs & Pharmaceuticals Ltd.India
Actimed, Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd.
DRP-3126-02
Jul 14, 2029
NoneClopidogrel (as bisulfate)
75 mg Film-Coated TabletClear PVC/Alu Blister Pack x 10’s (Box of 100’s)
Rx
Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)India
Diafarm, Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd.
DRP-3126-07
Jul 14, 2029
NoneClopidogrel Bisulfate
75 mg Film-Coated TabletFoil Strip x 10's Box of 50's
Rx
Ajanta Pharma LimitedIndia
RITEMED PHILS., INC.
DRP-3168
Jul 10, 2029
NoneClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu Foil Strip x 4''s (Box of 100's)
Rx
Interphil Laboratories, Inc.Philippines
ROSE PHARMACY, INCORPORATED
DRP-3793-01
Jun 13, 2028
NoneClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu Foil Strip x 4's (Box of 100's)
Rx
Interphil Laboratories, Inc.Philippines
Neodrug Inc.
DRP-3793-03
Jun 13, 2028
NoneClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100’s)
Rx
Stallion Laboratories Pvt. Ltd.India
PharmaVital Corp.Importer: Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd.
DRP-4698-02
Sep 13, 2028
NoneClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Mediwin PharmaceuticalsIndia
Dynasty PharmaceuticalsImporter: Ambica International Corporation
DRP-6560-01
Oct 10, 2030
NoneClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's and 100's)
Rx
Hizon Laboratories, Inc.Philippines
—
DRP-6838
Nov 17, 2029
NoneClopidogrel (as Bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's
Rx
Mepro Pharmaceutical Private LimitedIndia
Actimed, Inc.Importer: Medethix, Inc.
DRP-8514-01
Nov 22, 2027
NoneClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
Rx
Zim Laboratories LimitedIndia
Qualifirst Health, Inc.Importer: Medinova Pharmaceutical, Inc.
DRP-9166-14
Sep 21, 2030
NoneClopidogrel (as bisulfate)
75 mg TabletPA/Alu/PVC Blister Pack x 14's
Rx
Sanofi Winthrop IndustrieFrance
Importer: Sanofi Pasteur Inc.
DR-XY32673
Mar 12, 2031
NoneClopidogrel (as bisulfate)
75 mg TabletAlu/Alu Blister Pack x 10’s Box of 30’s
Rx
Sun Pharmaceuticals Industries LimitedIndia
Importer: Sun Pharma Philippines, Inc.
DRP-2008
Mar 31, 2030
NoneClopidogrel (as bisulfate)
75mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
Rx
Mepro Pharmaceuticals Private LimitedIndia
Vivilon Pharmaceuticals Inc.Importer: Medethix, Inc.
DRP-8514-03
Nov 22, 2027
NoneClopidogrel (as Bisulfate)
75mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
Rx
Mepro Pharmaceuticals Private LimitedIndia
Uniqure Pharma Inc.Importer: Medethix, Inc.
DRP-8514-05
Nov 22, 2027
NorplatClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 28's)
Rx
Getz Pharma Pvt. Ltd.Pakistan
Getz Pharma (Phils.), Inc.
DR-XY32200
Jul 30, 2030
NuclotClopidogrel
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
Rx
Centurion Laboratories Pvt. Ltd.India
Vitalife Pharma & Medical Supply IncImporter: Philgen Pharmaceuticals, Inc.
DRP-11057-04
Jan 20, 2027
OP-ReduclotClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Globela Pharma Private LimitedIndia
Orient Pearl Med Pharma Inc.Importer: AMB HK Enterprises Inc.
DRP-13933-1
May 18, 2028
OragrelClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's, 50's and 100's)
Rx
Zim Laboratories LimitedIndia
Suhitas Pharmaceuticals Inc.Importer: Orange Biotec Inc.Trader: Amegh Pharma Pvt. Ltd.
DRP-3250-02
Sep 20, 2031
PharmagrelClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Stallion Laboratories Pvt. Ltd.India
228 Pharma TradingImporter: Ambica International Corporation
DRP-2672-10
Jan 4, 2029
PidogrelClopidogrel
75 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Centurion Laboratories Pvt. Ltd.India
Meedpharma Medical Supplies & Equipment DistributorImporter: Philgen Pharmaceuticals Inc
DRP-11057-03
Jan 20, 2027
PigrelClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Lloyd Laboratories, Inc.Philippines
Trader: Philippine Home Pharmaceuticals
DR-XY39510
May 27, 2031
PlagerineClopidogrel (as Bisulfate)
75 mg Film Coated tabletAlu-Alu Blister Pack x 10's Box of 30's
Rx
Micro labs LimitedIndia
Brown & Burk Philippines Inc.
DRP-948
Jan 7, 2028
PlasmablocClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Magbro Healthcare Pvt. Ltd.India
Pharmakon Biotec, Inc.
DRP-10878
Dec 10, 2026
Plat-LowClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30's)
Rx
Globela Pharma Private LimitedIndia
CCL Pharmaceuticals (Philippines), Inc.Importer: AMB HK Enterprises Inc.
DRP-13489-01
Feb 27, 2028
PlatcloClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu-Alu Blister pack x 14's (Box of 1's)
Rx
Medreich Limited (Unit 3)India
Metro Drug, Inc.Importer: Paradigm Pharma (Philippines) Corporation
DRP-15191
May 22, 2029
PlatexanClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu blister pack x 10's (box of 30's and 100's)
Rx
Samjin Pharmaceutical Co., Ltd.Korea
Patriot Pharmaceuticals Corporation.
DR-XY49142
Jul 30, 2029
PlatexanClopidogrel (as bisulfate)
75 mg tabletAlu/Alu Blister Pack x 10's (Box of 30's); Alu/Alu Blister Pack x 15's (Box of 15's)
Rx
Apotex, Inc.Canada
Patriot Pharmaceuticals Corporation
DR-XY35075
Oct 29, 2028
PlatikonClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Healer's Lab (Unit II)India
Pharmakon Biotec, Inc.
DRP-16473
Mar 20, 2030
PlatzClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Stallion Laboratories Pvt. Ltd.India
The Cathay YSS Distributors Co., IncImporter: Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd.
DRP-4698-01
Sep 13, 2028
PlavicarClopidogrel (as bisulfate)
75 mg Film Coated TabletAlu/PVC Blister Pack x 10's (Box of 30's and 100's)
Rx
Hebei Tiancheng Pharmaceutical Co., Ltd.China
PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc.
DRP-15451-01
Jul 11, 2029
PlavidoClopidogrel (as Bisulfate)
75mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Fredun Pharmaceuticals LimitedIndia
AMB HK Enterprises, Inc.Importer: AMB HK Enterprises Inc.
DRP-12515
Aug 25, 2027
PlavihexClopidogrel
75 mg TabletAlu/Alu Blister Pack x 10’s (Box of 100's)
Rx
Flamingo Pharmaceuticals Ltd.India
Hexagon Pharmaceuticals
DRO-2140-01
Oct 26, 2029
PlavixClopidogrel (As Bisulfate)
300 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Sanofi Winthrop IndustrieFrance
Importer: Sanofi-Aventis Philippines, Inc.
DR-XY37405
Nov 17, 2027
PlavixClopidogrel (As Bisulfate)
75 mg Film Coated TabletAlu/Alu Blister Pack x 14's (Box of 14's)
Rx
Sanofi Winthrop IndustrieFrance
Importer: Sanofi-Aventis Philippines, Inc.
DRP-5643
Oct 7, 2027
PlogrelClopidogrel Bisulfate
75 mg Film-Coated TabletFoil Strip x 10's (Box of 50's)
Rx
Ajanta Pharma LimitedIndia
UNILAB, INC.
DRP-3168-01
Jul 16, 2029
PlogrilClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's); Alu/Clear PVC Blister Pack x 10's (Box of 30's)
Rx
Drugmaker's Laboratories Inc.Philippines
—
DRP-2267
Mar 29, 2032
PrimevixClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's and 100's)
Rx
Magbro Healthcare Pvt. Ltd.India
Life and Health Source Pharmaceutical Distribution Co.Importer: Pharmakon Biotec Inc.
DRP-10878-09
Dec 10, 2026
PurilClopidogrel (As Bisulfate)
75 mg Film -Coated TabletAlu/Alu Cold Forming Blister Pack x 10's (Box of 30's)
Rx
USV Private LimitedIndia
USV Pharma Philippines Inc.
DR-XY49760
Jul 2, 2031
RetaplavClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 10's, 30's, 50's and 100's)
Rx
BDA Healthcare Pvt. Ltd.India
Reta DrugImporter: Orange Biotec Inc.
DRP-15765-01
Sep 12, 2029
SaphlopidClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
Rx
Sapphire Lifesciences Pvt. Ltd.India
Nelpa Lifesciences, Inc.
DRP-7384
Oct 4, 2027
SAPHLOPID-GE75Clopidogrel (As Bisulfate)
75 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Genom Biotech Pvt. Ltd.India
Nelpa Lifesciences, Inc.
DRP-18235
Jun 2, 2031
ShegrelClopidogrel (as Bisulfate)
75 mg Film-Coated TabletAlu/White PVC Blister Pack x 10's (Box of 100's)
Rx
Medisure Laboratories Pakistan (Pvt.) LimitedPakistan
Malyka International Trading Corp.Importer: Accesspoint International Trading Inc.
DRP-6042-01
Apr 16, 2037
SkygrelClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Stallion Laboratories Pvt. Ltd.India
Qualifirst Health Inc.Importer: Ambica International Corporation
DRP-2672-07
Jan 4, 2029
SyclopidClopidogrel (as bisulfate)
6 mg/mL Syrup (Oral Drops)Alu/PVDC/PVC White Opaque Blister Pack x 10's Box of 100's; Alu/PVDC/PVC White Opaque Blister Pack x 7's Box of 28's
Rx
Sydenham Laboratories, Inc.Philippines
Sydenham Pharmaceuticals, Inc.
DRP-2202
Dec 1, 2029
SydogrelClopidogrel (as bisulfate)
75 mg Film Coated TabletAlu/Alu BlisterPack x 10's (Box of 100's)
Rx
The Madras PharmaceuticalsIndia
Synergen Pharma Inc.Trader: Synergen Asia Pte. Ltd.
DRP-6062
Sep 3, 2028
T-ClotClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.
DRP-15738
Sep 11, 2029
ThrombicareClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
Rx
Lloyd Laboratories, Inc.Philippines
Vitalink Health Products, Inc.Trader: Solvang Pharmaceuticals, Inc.
DRP-4028-02
Jul 14, 2031
TimibestClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Magbro Healthcare Pvt. Ltd.India
Littman Drug CorporationImporter: Pharmakon Biotec Inc.Trader: Sarva Pharmaceuticals Pvt. Ltd.
DRP-10878-01
Dec 10, 2026
TridogrelClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
Rx
Stallion Laboratories Pvt. Ltd.India
RSG Pharma TradingImporter: Ambica International Corporation
DRP-2672-04
Jan 4, 2029
TrombixClopidogrel (as bisulfate)
75 mg Film-Coated TabletBlister Pack x 14’s (Box of 14’s)
Rx
Standard Chem. & Pharm. Co., LtdChina
Phil Pharmawealth, Inc.
DR-XY38329
Aug 4, 2030
UnbrandedClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 10's)
Rx
Lloyd Laboratories, Inc.Philippines
Trader: Dr. Zen’s Research, Inc.
DR-XY38668
Oct 20, 2030
UnbrandedClopidogrel
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's in a box
Rx
Ferozsons Laboratories LimitedPakistan
First Global Trading Corporation
DR-XY44799
Sep 3, 2031
UnbrandedClopidogrel
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
Rx
Centurion Laboratories Pvt. Ltd.India
Philgen Pharmaceuticals Inc.
DRP-11057
Jan 20, 2032
UnbrandedClopidogrel (as Bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 100’s
Rx
XL Laboratories Pvt. Ltd.India
RiteMed Phils., Inc.Importer: Ambica International Corporation
DRP-1885-02
Sep 8, 2029
UnbrandedClopidogrel (as bisulfate)
75 mg Film-Coated TabletClear PVC/Alu Blister Pack x 10’s Box of 100’s
Rx
Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)India
RiteMED Phils., Inc.Importer: Ambica International Corporation
DRP-3126-04
Jul 14, 2029
UnbrandedClopidogrel (as bisulfate)
75 mg Film-Coated TabletClear PVC/Alu Blister Pack x 10’s Box of 100’s
Rx
Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)India
International Pharmaceuticals, Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd.
DRP-3126-05
Jul 14, 2029
UnbrandedClopidogrel (as bisulfate)
75 mg Film-Coated TabletClear PVC/Alu Blister Pack x 10’s (Box of 100’s)
Rx
Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)India
South Star DrugImporter: Ambica International CorporationTrader: Unosource Pharma Ltd.
DRP-3126-06
Jul 14, 2029
UnbrandedClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Lloyd Laboratories, Inc.Philippines
Watsons Personal Care Stores (Philippines), Inc.Trader: Solvang Pharmaceuticals, Inc.
DRP-4028-03
Jul 30, 2031
UnbrandedClopidogrel (as Bisulfate)
75mg Film-Coated Tablet
Rx
—
TGP Pharma Inc.
DRP-2267-03
Mar 29, 2027
ValdonClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/ PVC Blister Pack x 10’s (Box of 30’s and 100’s)
Rx
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Corbridge Group Phils., Inc.Importer: Amb Hk Enterprises Inc.
DRP-15451-02
Jul 11, 2029
VasclorixClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's, and 100's)
Rx
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-10878-12
Dec 10, 2026
Vexagril 75Clopidrogel (as bisulfate)Variant spelling
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s)
Rx
AKUMS DRUGS & PHARMACEUTICALS LTD.India
VE PHARMA INC.Trader: Vexxa Lifesciences Pvt. Ltd
DR-XY44065
Jan 29, 2030
VivelonClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
Rx
Micro Labs LimitedIndia
ADP Pharma CorporationImporter: Brown & Burk Phils., Inc.
DRP-948-01
Jan 7, 2028
XerevoClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
Rx
Stallion Laboratories Pvt. Ltd.India
Miraculin Pharma Inc.Importer: Ambica International Corporation
DRP-2672-08
Jan 4, 2029
ZandropilClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
Rx
Stallion Laboratories Pvt. Ltd.India
Altomed Pharmaceuticals, Inc.Importer: Ambica International Corporation
DRP-2672-12
Jan 4, 2029
ZeroclotClopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
Rx
Stallion Laboratories Pvt. Ltd.India
Primera Pharma CorporationImporter: Ambica International Corporation
DRP-2672-01
Jan 4, 2029
(no brand name)Clopidogrel (as bisulfate)
75 mg Film Coated TabletAlu/Alu Blister Pack x 7's (Box of 28's)
Rx
Bafna Pharmaceuticals LimitedIndia
Medethix, Inc.
DRP-16366
Feb 20, 2030
(no brand name)Clopidogrel (as bisulfate)
75 mg Film Coated TabletAlu/Alu Blister Pack x 14's (Box of 14's)
Rx
Sanofi Winthrop IndustrieFrance
Philusa CorporationImporter: Sanofi-Aventis Philippines, Inc.
DRP-5643-01
Oct 7, 2027
(no brand name)Clopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
Rx
Centurion Laboratories Pvt. Ltd.India
Philgen Pharmaceuticals, Inc.
DRP-11515
Apr 1, 2027
(no brand name)Clopidogrel (As Bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10 Blister packs x 10 Tablets)
Rx
Stallion Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-13204
Dec 28, 2027
(no brand name)Clopidogrel (as bisulfate)
75 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's)
Rx
Akums Drugs & Pharmaceuticals Ltd. (Plant I - Solid Oral Dosage Facility)India
Ambica International Corporation.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd.
DRP-14741
Dec 20, 2028

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

United States (label)

Dosage forms and strengths (US label) US FDA label

3 DOSAGE FORMS AND STRENGTHS 75 mg tablets: Pink, round, biconvex, film-coated tablets debossed with "75" on one side and "1171" on the other 300 mg tablets: Pink, oblong, film-coated tablets debossed with "300" on one side and "1332" on the other Film-coated tablets: 75 mg, 300 mg (3)

Warnings/Precautions

The boxed warning is shown at the top of this page.

Warnings and precautions (US label) US FDA label
  • CYP2C19 inhibitors: Avoid concomitant use of omeprazole or esomeprazole. (5.1)
  • Bleeding: Plavix increases risk of bleeding. (5.2)
  • Discontinuation: Premature discontinuation increases risk of cardiovascular events. Discontinue 5 days prior to elective surgery that has a major risk of bleeding. (5.3)
  • Thrombotic thrombocytopenic purpura (TTP) has been reported. (5.4)
  • Cross-reactivity among thienopyridines has been reported. (5.5)
5.1 Diminished Antiplatelet Activity in Patients with Impaired CYP2C19 Function

5.1 Diminished Antiplatelet Activity in Patients with Impaired CYP2C19 Function Clopidogrel is a prodrug. Inhibition of platelet aggregation by clopidogrel is achieved through an active metabolite. The metabolism of clopidogrel to its active metabolite can be impaired by genetic variations in CYP2C19 [see Boxed Warning].

The metabolism of clopidogrel can also be impaired by drugs that inhibit CYP2C19, such as omeprazole or esomeprazole. Avoid concomitant use of Plavix with omeprazole or esomeprazole because both significantly reduce the antiplatelet activity of Plavix [see Drug Interactions (7.1)].

5.2 General Risk of Bleeding

5.2 General Risk of Bleeding P2Y12 inhibitors (thienopyridines), including Plavix, increase the risk of bleeding. P2Y12 inhibitors (thienopyridines), inhibit platelet aggregation for the lifetime of the platelet (7–10 days). Because the half-life of clopidogrel's active metabolite is short, it may be possible to restore hemostasis by administering exogenous platelets; however, platelet transfusions within 4 hours of the loading dose or 2 hours of the maintenance dose may be less effective.

Use of drugs that induce the activity of CYP2C19 would be expected to result in increased drug levels of the active metabolite of clopidogrel and might potentiate the bleeding risk. As a precaution, avoid concomitant use of strong CYP2C19 inducers [see Drug Interactions (7.1) and Clinical Pharmacology (12.3)]. Risk factors for bleeding include concomitant use of other drugs that increase the risk of bleeding (e.g., anticoagulants, antiplatelet agents, and chronic use of NSAIDs) [see Drug Interactions (7.4, 7.5, 7.6, 7.7)].

5.3 Discontinuation of Plavix

5.3 Discontinuation of Plavix Discontinuation of Plavix increases the risk of cardiovascular events. If Plavix must be temporarily discontinued (e.g., to treat bleeding or for surgery with a major risk of bleeding), restart it as soon as possible. When possible, interrupt therapy with Plavix for five days prior to such surgery.

Resume Plavix as soon as hemostasis is achieved.

5.4 Thrombotic Thrombocytopenic Purpura (TTP)

5.4 Thrombotic Thrombocytopenic Purpura (TTP) TTP, sometimes fatal, has been reported following use of Plavix, sometimes after a short exposure (<2 weeks). TTP is a serious condition that requires urgent treatment including plasmapheresis (plasma exchange). It is characterized by thrombocytopenia, microangiopathic hemolytic anemia (schistocytes [fragmented RBCs] seen on peripheral smear), neurological findings, renal dysfunction, and fever [see Adverse Reactions (6.2)].

5.5 Cross-Reactivity

5.5 Cross-Reactivity among Thienopyridines Hypersensitivity including rash, angioedema or hematologic reaction has been reported in patients receiving Plavix, including patients with a history of hypersensitivity or hematologic reaction to other thienopyridines [see Contraindications (4.2) and Adverse Reactions (6.2)].

Drug interactions

Drug interactions (US label) US FDA label
  • CYP2C19 inducers: Increases levels of clopidogrel active metabolite and increases platelet inhibition. (7.1)
  • Opioids: Decreased exposure to clopidogrel. Consider use of parenteral antiplatelet agent. (7.3)
  • Nonsteroidal anti-inflammatory drugs (NSAIDs), warfarin, selective serotonin and serotonin norepinephrine reuptake inhibitors (SSRIs, SNRIs): Increases risk of bleeding. (7.4, 7.5, 7.6)
  • Other Antiplatelet Agents: Increases the risk of bleeding due to an additive effect. (7.7)
  • Repaglinide (CYP2C8 substrates): Increases substrate plasma concentrations. (7.8)
7.1 CYP2C19 Inducers

7.1 CYP2C19 Inducers Since clopidogrel is metabolized to its active metabolite partly by CYP2C19, use of drugs that induce the activity of this enzyme would be expected to result in increased drug levels of the active metabolite of clopidogrel. Rifampin strongly induces CYP2C19 resulting to both an increase level of clopidogrel active metabolite and platelet inhibition, which in particular might potentiate the risk of bleeding.

As a precaution, avoid concomitant use of strong CYP2C19 inducers [see Warnings and Precautions (5.1) and Clinical Pharmacology (12.3)].

7.2 CYP2C19 Inhibitors

7.2 CYP2C19 Inhibitors Clopidogrel is metabolized to its active metabolite in part by CYP2C19. Concomitant use of drugs that inhibit the activity of this enzyme results in reduced plasma concentrations of the active metabolite of clopidogrel and a reduction in platelet inhibition [see Warnings and Precautions (5.1)]. Omeprazole or Esomeprazole Avoid concomitant use of Plavix with omeprazole or esomeprazole.

In clinical studies, omeprazole was shown to reduce significantly the antiplatelet activity of Plavix when given concomitantly or 12 hours apart. A similar reduction in antiplatelet activity was observed with esomeprazole when given concomitantly with Plavix. Dexlansoprazole, lansoprazole, and pantoprazole had less effect on the antiplatelet activity of Plavix than did omeprazole or esomeprazole [see Warnings and Precautions (5.1) and Clinical Pharmacology (12.3)].

7.3 Opioids

7.3 Opioids As with other oral P2Y 12 inhibitors, coadministration of opioid agonists delay and reduce the absorption of clopidogrel, presumably because of slowed gastric emptying, resulting in reduced exposure to its metabolites [see Clinical Pharmacology (12.3)]. Consider the use of a parenteral antiplatelet agent in acute coronary syndrome patients requiring coadministration of morphine or other opioid agonists.

7.4 Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Coadministration of Plavix

7.4 Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Coadministration of Plavix and NSAIDs increases the risk of gastrointestinal bleeding.

7.5 Warfarin (CYP2C9 Substrates)

7.5 Warfarin (CYP2C9 Substrates) Although the administration of clopidogrel 75 mg per day did not modify the pharmacokinetics of S-warfarin (a CYP2C9 substrate) or INR in patients receiving long-term warfarin therapy, coadministration of Plavix with warfarin increases the risk of bleeding because of independent effects on hemostasis. However, at high concentrations in vitro, clopidogrel inhibits CYP2C9.

7.6 SSRIs and SNRIs

7.6 SSRIs and SNRIs Since selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) affect platelet activation, the concomitant administration of SSRIs and SNRIs with clopidogrel may increase the risk of bleeding.

7.7 Other Antiplatelet Agents

7.7 Other Antiplatelet Agents Coadministration of antiplatelet agents increase the risk of bleeding due to an additive effect. Promptly evaluate any signs or symptoms of blood loss if patients are treated concomitantly with other antiplatelet agents [see Warnings and Precautions (5.2)].

7.8 Repaglinide (CYP2C8 Substrates)

7.8 Repaglinide (CYP2C8 Substrates) The acyl-β-glucuronide metabolite of clopidogrel is a strong inhibitor of CYP2C8. Plavix can increase the systemic exposure to drugs that are primarily cleared by CYP2C8, thereby needing dose adjustment and appropriate monitoring. Plavix increased repaglinide exposures by 3.9-fold to 5.1-fold [see Clinical Pharmacology (12.3)].

Avoid concomitant use of repaglinide with Plavix. If concomitant use cannot be avoided, initiate repaglinide at 0.5 mg before each meal and do not exceed a total daily dose of 4 mg. Increased frequency of glucose monitoring may be required during concomitant use.

Metabolism and transporters (CYP, P-gp, OATP; US label) US FDA label

The active metabolite is formed mostly by CYP2C19 with contributions from several other CYP enzymes, including CYP1A2, CYP2B6 and CYP3A.

Drug Interactions Effect of other drugs on Plavix Clopidogrel is metabolized to its active metabolite in part by CYP2C19.

CYP2C19 inducers Concomitant use of strong inducers of CYP2C19 results in increased plasma concentration of the active metabolite of clopidogrel and an increase in platelet inhibition.

CYP2C19 inhibitors Concomitant use of certain inhibitors of this enzyme results in reduced plasma concentrations of the active metabolite of clopidogrel and a reduction in platelet inhibition.

Effect of Plavix on other drugs In vitro studies have shown that the glucuronide metabolite of clopidogrel is a strong inhibitor of CYP2C8.

7 DRUG INTERACTIONS CYP2C19 inducers: Increases levels of clopidogrel active metabolite and increases platelet inhibition.

( 7.7 ) Repaglinide (CYP2C8 substrates): Increases substrate plasma concentrations.

( 7.8 ) 7.1 CYP2C19 Inducers Since clopidogrel is metabolized to its active metabolite partly by CYP2C19, use of drugs that induce the activity of this enzyme would be expected to result in increased drug levels of the active metabolite of clopidogrel.

Adverse reactions

Adverse reactions (US label) US FDA label
  • The following serious adverse reactions are discussed below and elsewhere in the labeling: Bleeding [see Warnings and Precautions (5.2)] Thrombotic thrombocytopenic purpura [see Warnings and Precautions (5.4)] Bleeding, including life-threatening and fatal bleeding, is the most commonly reported adverse reaction. (6.1)
  • To report SUSPECTED ADVERSE REACTIONS, contact sanofi-aventis U.S. LLC at 1-800-633-1610 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
6.1 Clinical Trials Experience

6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions and durations of follow-up, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. Plavix has been evaluated for safety in more than 54,000 patients, including over 21,000 patients treated for one year or more.

The clinically important adverse reactions observed in trials comparing Plavix plus aspirin to placebo plus aspirin and trials comparing Plavix alone to aspirin alone are discussed below. Bleeding CURE In CURE, Plavix use with aspirin was associated with an increase in major bleeding (primarily gastrointestinal and at puncture sites) compared to placebo with aspirin (see Table 1).

The incidence of intracranial hemorrhage (0.1%) and fatal bleeding (0.2%) were the same in both groups. Other bleeding events that were reported more frequently in the clopidogrel group were epistaxis, hematuria, and bruise. The overall incidence of bleeding is described in Table 1. Table 1: CURE Incidence of Bleeding Complications (% patients) Event Plavix (+ aspirin) (n=6259) Placebo (+ aspirin) (n=6303) Major bleeding Life-threatening and other major bleeding. 3.7 2.7 Life-threatening bleeding 2.2 1.8 Fatal 0.2 0.2 5 g/dL hemoglobin drop 0.9 0.9 Requiring surgical intervention 0.7 0.7 Hemorrhagic strokes 0.1 0.1 Requiring inotropes 0.5 0.5 Requiring transfusion (≥4 units) 1.2 1.0 Other major bleeding 1.6 1.0 Significantly disabling 0.4 0.3 Intraocular bleeding with significant loss of vision 0.05 0.03 Requiring 2–3 units of blood 1.3 0.9 Minor bleeding Led to interruption of study medication. 5.1 2.4 COMMIT In COMMIT, similar rates of major bleeding were observed in the Plavix and placebo groups, both of which also received aspirin (see Table 2).

Table 2: Incidence of Bleeding Events in COMMIT (% patients) Type of Bleeding Plavix (+ aspirin) (n=22961) Placebo (+ aspirin) (n=22891) p-value Major Major bleeds were cerebral bleeds or noncerebral bleeds thought to have caused death or that required transfusion. noncerebral or cerebral bleeding 0.6 0.5 0.59 Major noncerebral 0.4 0.3 0.48 Fatal 0.2 0.2 0.90 Hemorrhagic stroke 0.2 0.2 0.91 Fatal 0.2 0.2 0.81 Other noncerebral bleeding (nonmajor) 3.6 3.1 0.005 Any noncerebral bleeding 3.9 3.4 0.004 CAPRIE (Plavix vs Aspirin) In CAPRIE, gastrointestinal hemorrhage occurred at a rate of 2.0% in those taking Plavix versus 2.7% in those taking aspirin; bleeding requiring hospitalization occurred in 0.7% and 1.1%, respectively. The incidence of intracranial hemorrhage was 0.4% for Plavix compared to 0.5% for aspirin.

Other bleeding events that were reported more frequently in the Plavix group were epistaxis and hematoma. Other Adverse Events In CURE and CHARISMA, which compared Plavix plus aspirin to aspirin alone, there was no difference in the rate of adverse events (other than bleeding) between Plavix and placebo. In CAPRIE, which compared Plavix to aspirin, pruritus was more frequently reported in those taking Plavix.

No other difference in the rate of adverse events (other than bleeding) was reported.

6.2 Postmarketing Experience

6.2 Postmarketing Experience The following adverse reactions have been identified during postapproval use of Plavix. Because these reactions are reported voluntarily from a population of an unknown size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Hemorrhages, including those with fatal outcome, have been reported in patients treated with Plavix.

Blood and lymphatic system disorders: Agranulocytosis, aplastic anemia/pancytopenia, thrombotic thrombocytopenic purpura (TTP), acquired hemophilia A Gastrointestinal disorders: Colitis (including ulcerative or lymphocytic colitis), pancreatitis, stomatitis, gastric/duodenal ulcer, diarrhea General disorders and administration site condition: Fever Hepatobiliary disorders: Acute liver failure, hepatitis (noninfectious), abnormal liver function test Immune system disorders: Hypersensitivity reactions, anaphylactoid reactions, serum sickness, insulin autoimmune syndrome, which can lead to severe hypoglycemia Musculoskeletal, connective tissue and bone disorders: Myalgia, arthralgia, arthritis Nervous system disorders: Taste disorders, headache, ageusia Psychiatric disorders: Confusion, hallucinations Respiratory, thoracic and mediastinal disorders: Bronchospasm, interstitial pneumonitis, eosinophilic pneumonia Renal and urinary disorders: Increased creatinine levels Skin and subcutaneous tissue disorders: Maculopapular, erythematous or exfoliative rash, urticaria, bullous dermatitis, eczema, toxic epidermal necrolysis, Stevens-Johnson syndrome, acute generalized exanthematous pustulosis (AGEP), angioedema, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms (DRESS), erythema multiforme, lichen planus, generalized pruritus Vascular disorders: Vasculitis, hypotension

Adverse reaction frequency tables (US label) US FDA label
Table 1: CURE Incidence of Bleeding Complications (% patients)
EventPlavix (+ aspirin) (n=6259)Placebo (+ aspirin) (n=6303)
Major bleedingLife-threatening and other major bleeding.3.72.7
Life-threatening bleeding2.21.8
Fatal0.20.2
5 g/dL hemoglobin drop0.90.9
Requiring surgical intervention0.70.7
Hemorrhagic strokes0.10.1
Requiring inotropes0.50.5
Requiring transfusion (≥4 units)1.21.0
Other major bleeding1.61.0
Significantly disabling0.40.3
Intraocular bleeding with significant loss of vision0.050.03
Requiring 2–3 units of blood1.30.9
Minor bleedingLed to interruption of study medication.5.12.4
Table 2: Incidence of Bleeding Events in COMMIT (% patients)
Type of BleedingPlavix (+ aspirin) (n=22961)Placebo (+ aspirin) (n=22891)p-value
MajorMajor bleeds were cerebral bleeds or noncerebral bleeds thought to have caused death or that required transfusion. noncerebral or cerebral bleeding0.60.50.59
Major noncerebral0.40.30.48
Fatal0.20.20.90
Hemorrhagic stroke 0.20.20.91
Fatal0.20.20.81
Other noncerebral bleeding (nonmajor)3.63.10.005
Any noncerebral bleeding3.93.40.004

Pregnancy considerations

Pregnancy (US label) US FDA label

8.1 Pregnancy Risk Summary Available data from cases reported in published literature and postmarketing surveillance with clopidogrel use in pregnant women have not identified any drug-associated risks for major birth defects or miscarriage [see Data]. There are risks to the pregnant woman and fetus associated with myocardial infarction and stroke [see Clinical Considerations].

No evidence of fetotoxicity was observed when clopidogrel was administered to pregnant rats and rabbits during organogenesis at doses corresponding to 65 and 78 times the recommended daily human dose [see Data]. The estimated background risk of major birth defects and miscarriage for the indicated populations is unknown.

All pregnancies have a background risk of birth defects, loss, or other adverse outcomes. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. Clinical Considerations Disease-associated maternal and/or embryo/fetal risk Myocardial infarction and stroke are medical emergencies.

Therapy for the pregnant woman should not be withheld because of potential concerns regarding the effects of clopidogrel on the fetus. Labor or delivery Clopidogrel use during labor or delivery will increase the risk of maternal bleeding and hemorrhage. Avoid neuraxial blockade during clopidogrel use because of the risk of spinal hematoma.

When possible, discontinue clopidogrel 5 to 7 days prior to labor, delivery, or neuraxial blockade. Data Human data The available data from published case reports over two decades of postmarketing use have not identified an association with clopidogrel use in pregnancy and major birth defects, miscarriage, or adverse fetal outcomes.

Animal data Embryo-fetal developmental toxicology studies were performed in pregnant rats and rabbits with doses up to 500 and 300 mg/kg/day, respectively, administered during organogenesis. These doses, corresponding to 65 and 78 times the recommended daily human dose, respectively, on a mg/m 2 basis, revealed no evidence of impaired fertility or fetotoxicity due to clopidogrel.

Mechanism of action

12.1 Mechanism of Action Clopidogrel is an inhibitor of platelet activation and aggregation through the irreversible binding of its active metabolite to the P2Y 12 class of ADP receptors on platelets.

US FDA label

Pharmacodynamics

Pharmacodynamics (US label) US FDA label

12.2 Pharmacodynamics Clopidogrel must be metabolized by CYP450 enzymes to produce the active metabolite that inhibits platelet aggregation. The active metabolite of clopidogrel selectively inhibits the binding of adenosine diphosphate (ADP) to its platelet P2Y 12 receptor and the subsequent ADP-mediated activation of the glycoprotein GPIIb/IIIa complex, thereby inhibiting platelet aggregation.

This action is irreversible. Consequently, platelets exposed to clopidogrel's active metabolite are affected for the remainder of their lifespan (about 7 to 10 days). Platelet aggregation induced by agonists other than ADP is also inhibited by blocking the amplification of platelet activation by released ADP. Dose-dependent inhibition of platelet aggregation can be seen 2 hours after single oral doses of Plavix.

Repeated doses of 75 mg Plavix per day inhibit ADP-induced platelet aggregation on the first day, and inhibition reaches steady state between Day 3 and Day 7. At steady state, the average inhibition level observed with a dose of 75 mg Plavix per day was between 40% and 60%. Platelet aggregation and bleeding time gradually return to baseline values after treatment is discontinued, generally in about 5 days.

Geriatric Patients Elderly (≥75 years) and young healthy subjects had similar effects on platelet aggregation. Renally Impaired Patients After repeated doses of 75 mg Plavix per day, patients with severe renal impairment (creatinine clearance from 5 to 15 mL/min) and moderate renal impairment (creatinine clearance from 30 to 60 mL/min) showed low (25%) inhibition of ADP-induced platelet aggregation.

Hepatically Impaired Patients After repeated doses of 75 mg Plavix per day for 10 days in patients with severe hepatic impairment, inhibition of ADP-induced platelet aggregation was similar to that observed in healthy subjects. Gender In a small study comparing men and women, less inhibition of ADP-induced platelet aggregation was observed in women.

Pharmacokinetics

Half-life and elimination (verbatim, US label)

Absorption is at least 50%, based on urinary excretion of clopidogrel metabolites.

Elimination Following an oral dose of 14 C-labeled clopidogrel in humans, approximately 50% of total radioactivity was excreted in urine and approximately 46% in feces over the 5 days post dosing.

After a single, oral dose of 75 mg, clopidogrel has a half-life of approximately 6 hours.

The half-life of the active metabolite is about 30 minutes.

Pharmacokinetics (US label) US FDA label

12.3 Pharmacokinetics Clopidogrel is a prodrug and is metabolized to a pharmacologically active metabolite and inactive metabolites. Absorption After single and repeated oral doses of 75 mg per day, clopidogrel is rapidly absorbed. Absorption is at least 50%, based on urinary excretion of clopidogrel metabolites. Effect of food Plavix can be administered with or without food.

In a study in healthy male subjects when Plavix 75 mg per day was given with a standard breakfast, mean inhibition of ADP-induced platelet aggregation was reduced by less than 9%. The active metabolite AUC 0–24 was unchanged in the presence of food, while there was a 57% decrease in active metabolite C max. Similar results were observed when a Plavix 300 mg loading dose was administered with a high-fat breakfast.

Metabolism Clopidogrel is extensively metabolized by two main metabolic pathways: one mediated by esterases and leading to hydrolysis into an inactive carboxylic acid derivative (85% of circulating metabolites) and one mediated by multiple cytochrome P450 enzymes. Cytochromes first oxidize clopidogrel to a 2-oxo-clopidogrel intermediate metabolite.

Subsequent metabolism of the 2-oxo-clopidogrel intermediate metabolite results in formation of the active metabolite, a thiol derivative of clopidogrel. The active metabolite is formed mostly by CYP2C19 with contributions from several other CYP enzymes, including CYP1A2, CYP2B6 and CYP3A. The active thiol metabolite binds rapidly and irreversibly to platelet receptors, thus inhibiting platelet aggregation for the lifespan of the platelet.

The C max of the active metabolite is twice as high following a single 300 mg clopidogrel loading dose as it is after four days of 75 mg maintenance dose. C max occurs approximately 30 to 60 minutes after dosing. In the 75 to 300 mg dose range, the pharmacokinetics of the active metabolite deviates from dose proportionality: 4-fold the dose results in 2.0-fold and 2.7-fold the C max and AUC, respectively.

Elimination Following an oral dose of 14 C-labeled clopidogrel in humans, approximately 50% of total radioactivity was excreted in urine and approximately 46% in feces over the 5 days post dosing. After a single, oral dose of 75 mg, clopidogrel has a half-life of approximately 6 hours. The half-life of the active metabolite is about 30 minutes.

Drug Interactions Effect of other drugs on Plavix Clopidogrel is metabolized to its active metabolite in part by CYP2C19. CYP2C19 inducers Concomitant use of strong inducers of CYP2C19 results in increased plasma concentration of the active metabolite of clopidogrel and an increase in platelet inhibition. Rifampin: Coadministration of rifampin 300 mg twice daily for 7 days with 600 mg loading dose of clopidogrel in healthy adults increased the mean AUC and C max of clopidogrel's thiol metabolites by 3.8-fold.

Mean inhibition of platelet aggregation at 4 hours post dose was 34% higher in the presence of rifampin compared to clopidogrel administered alone. CYP2C19 inhibitors Concomitant use of certain inhibitors of this enzyme results in reduced plasma concentrations of the active metabolite of clopidogrel and a reduction in platelet inhibition.

Proton pump inhibitors (PPI) The effect of proton pump inhibitors (PPI) on the systemic exposure to the clopidogrel active metabolite following multiple doses of Plavix 75 mg evaluated in dedicated drug interaction studies is presented in Figure 1. Figure 1: Exposure to Clopidogrel Active Metabolite Following Multiple Doses of Plavix 75 mg Alone or with Proton Pump Inhibitors (PPIs) Pharmacodynamic and pharmacokinetic parameters measured in these studies showed that the interaction was highest with omeprazole and least with dexlansoprazole.

Figure Opioids Coadministration of 5 mg intravenous morphine with 600 mg loading dose of clopidogrel in healthy adults decreased the AUC and C max of clopidogrel's thiol metabolites by 34%. Mean platelet aggregation was higher up to 2 to 4 hours with morphine coadministration. Effect of Plavix on other drugs In vitro studies have shown that the glucuronide metabolite of clopidogrel is a strong inhibitor of CYP2C8.

Concomitant administration of repaglinide with Plavix increased the systemic exposure to repaglinide (AUC 0–∞) by 5.1-fold following the loading dose (300 mg) and by 3.9-fold on day 3 of the maintenance dose (75 mg) of Plavix [see Drug Interactions (7.6)].

Formulary and pricing (Philippines)

Government price references

PreparationPrice (PHP)UnitType
Clopidogrel 75 mg Tablet₱0.92–₱2.80Reference ₱1.11per tabletDPRI procurement range
75 mg tablet₱20.25per tabletPhilHealth GAMOT fixed fee

PhilHealth GAMOT fixed fee paid to the accredited GAMOT pharmacy per unit dispensed Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)

These are government procurement and reimbursement references, not retail prices. Sources:

Formulary and coverage

Philippine National FormularyListed as Clopidogrel
PNF listingOral: 75 mg tablet
PhilHealth GAMOTYes (listed since July 28, 2025)

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Plavix · Sanofi-Aventis U.S. LLC [US FDA-approved label, version 5, May 30, 2025]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de8b0b67-eb25-4684-83b5-7ad785314227
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  3. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
  4. PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
  5. PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
  6. DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .